Rockefeller Capital Management’s Progress Software PRGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Buy
3,259
+520
+19% +$15.4K ﹤0.01% 2942
2026
Q1
$70.3K Buy
2,739
+1,407
+106% +$53.8K ﹤0.01% 3074
2025
Q4
$57.3K Buy
1,332
+877
+193% +$38.2K ﹤0.01% 3008
2025
Q3
$20K Buy
+455
New +$21K ﹤0.01% 3351
2023
Q1
Sell
-229
Closed -$11K 3406
2022
Q4
$11K Hold
229
﹤0.01% 3047
2022
Q3
$9K Sell
229
-100
-30% -$4.62K ﹤0.01% 3145
2022
Q2
$14K Buy
329
+139
+73% +$6.62K ﹤0.01% 2950
2022
Q1
$8K Buy
190
+1
+0.5% +$45 ﹤0.01% 3168
2021
Q4
$9K Sell
189
-245
-56% -$12.2K ﹤0.01% 3032
2021
Q3
$21K Sell
434
-480
-53% -$22.1K ﹤0.01% 2576
2021
Q2
$42K Buy
+914
New +$41.4K ﹤0.01% 2156
2020
Q3
Sell
-23
Closed -$1K 2748
2020
Q2
$1K Buy
+23
New +$876 ﹤0.01% 2491
2019
Q4
Sell
-265
Closed -$10K 2172
2019
Q3
$10K Hold
265
﹤0.01% 1430
2019
Q2
$12K Buy
+265
New +$11.5K ﹤0.01% 1180

Other funds holding PRGS

Rockefeller Capital Management's PRGS Position: Q2 2026 in Review

Rockefeller Capital Management increased its Progress Software (PRGS) stake by 19% in Q2 2026, buying an estimated $15.4K and bringing the position to 3,259 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Rockefeller Capital Management first reported a position in PRGS in Q2 2019 and has held it in 14 quarters since. 293 funds tracked by Wall St. Rank hold PRGS as of Q2 2026.

  • Rockefeller Capital Management held 3,259 shares of Progress Software worth $109K as of Q2 2026.
  • Rockefeller Capital Management bought 520 Progress Software shares in Q2 2026, an estimated $15.4K.
  • Progress Software made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2942 holding.
  • Rockefeller Capital Management first reported a position in Progress Software in Q2 2019 and has held it in 14 quarters since.
  • 293 funds tracked by Wall St. Rank held Progress Software as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.